Notably, NAPRT expression is often downregulated in several human cancers with EMT-like features, including gastric cancer (GC) 21, colorectal cancer (CRC), and pancreatic cancer (PAAD) (Figure 3B). This evidence concerns the gene NAPRT and pancreatic adenocarcinoma.